National, Regional, and Worldwide Epidemiology of Psoriasis: Systematic Analysis and Modelling Study

Overview

Journal BMJ

Specialty General Medicine

Date 2020 May 30

PMID 32467098

Citations 352

Authors

Rosa Parisi

Ireny Y K Iskandar

Evangelos Kontopantelis

Matthias Augustin

Christopher E M Griffiths

Darren M Ashcroft

Affiliations

Soon will be listed here.

Abstract

Objective: To systematically review and provide information on the incidence of psoriasis and quantify global, regional, and country specific estimates of its prevalence.

Design: Systematic review and meta-analysis.

Data Sources: Medline, Embase, Web of Science, SciELO, Korean Journal Databases, Russian Science Citation Index, WPRIM, SaudiMedLit, Informit, IndMed, and HERDIN were searched systematically from their inception dates to October 2019.

Methods: Studies were included if they reported on the incidence or prevalence of psoriasis in the general population. Incidence data were summarised descriptively, whereas bayesian hierarchical models were fitted to estimate the global, regional, and country specific prevalence of psoriasis.

Results: 41 164 records were identified and 168 studies met the inclusion criteria. In adults, the incidence of psoriasis varied from 30.3 per 100 000 person years (95% confidence interval 26.6 to 34.1) in Taiwan to 321.0 per 100 000 person years in Italy. The prevalence of psoriasis varied from 0.14% (95% uncertainty interval 0.05% to 0.40%) in east Asia to 1.99% (0.64% to 6.60%) in Australasia. The prevalence of psoriasis was also high in western Europe (1.92%, 1.07% to 3.46%), central Europe (1.83%, 0.62% to 5.32%), North America (1.50%, 0.63% to 3.60%), and high income southern Latin America (1.10%, 0.36% to 2.96%).

Conclusions: Eighty one per cent of the countries of the world lack information on the epidemiology of psoriasis. The disease occurs more frequently in adults than in children. Psoriasis is unequally distributed across geographical regions; it is more frequent in high income countries and in regions with older populations. The estimates provided can help guide countries and the international community when making public health decisions on the appropriate management of psoriasis and assessing its natural history over time.

Systematic Review Registration: PROSPERO CRD42019160817.

Citing Articles

The prevalence and risk of allergic rhinitis in psoriasis patients: a systematic review and meta-analysis.

Untaaveesup S, Amnartpanich T, Leelakanok N, Owattanapanich W, Kantagowit P, Dendumrongsup W Sci Rep. 2025; 15(1):9009.

PMID: 40089525 DOI: 10.1038/s41598-025-86779-1.

High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR).

Shams K, Montgomery J, Morley J, Gerasimaviciute V, Seesaghur A, Neasham D Dermatol Ther (Heidelb). 2025; .

PMID: 40080321 DOI: 10.1007/s13555-025-01358-6.

Influence of rs2280883 and rs3761548 Variants on IL-10 and TGF-β1 Serum Levels and Plaque Psoriasis Risk in the Mexican Population.

Hernandez-Bello J, Preciado-Aguiar M, Munoz-Valle J, Banos-Hernandez C, Garcia-Arellano S, Alvarado-Navarro A Int J Mol Sci. 2025; 26(5).

PMID: 40076417 PMC: 11898888. DOI: 10.3390/ijms26051789.

Multiple Biologics Treatment Failures in Patients with Psoriasis: A Case Series of 4 Patients.

Jensen M, Loft N, Zachariae C, Skov L Acta Derm Venereol. 2025; 105:adv42987.

PMID: 40059467 PMC: 11904832. DOI: 10.2340/actadv.v105.42987.

Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis.

Phan D, Bewley A, Laws P, Mackenzie T, Smith C, Griffiths C JAMA Dermatol. 2025; .

PMID: 40042863 PMC: 11883583. DOI: 10.1001/jamadermatol.2025.0055.

References

Hay R, Johns N, Williams H, Bolliger I, Dellavalle R, Margolis D . The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2013; 134(6):1527-1534. DOI: 10.1038/jid.2013.446. View

Tollefson M, Crowson C, McEvoy M, Kremers H . Incidence of psoriasis in children: a population-based study. J Am Acad Dermatol. 2009; 62(6):979-87. PMC: 3818908. DOI: 10.1016/j.jaad.2009.07.029. View

Parisi R, Symmons D, Griffiths C, Ashcroft D . Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2012; 133(2):377-85. DOI: 10.1038/jid.2012.339. View

. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

Enamandram M, Kimball A . Psoriasis epidemiology: the interplay of genes and the environment. J Invest Dermatol. 2013; 133(2):287-9. DOI: 10.1038/jid.2012.434. View

Egeberg A, Andersen Y, Thyssen J . Prevalence and characteristics of psoriasis in Denmark: findings from the Danish skin cohort. BMJ Open. 2019; 9(3):e028116. PMC: 6475143. DOI: 10.1136/bmjopen-2018-028116. View

Icen M, Crowson C, McEvoy M, Dann F, Gabriel S, Kremers H . Trends in incidence of adult-onset psoriasis over three decades: a population-based study. J Am Acad Dermatol. 2009; 60(3):394-401. PMC: 3028518. DOI: 10.1016/j.jaad.2008.10.062. View

Javitz H, Ward M, Farber E, Nail L, Vallow S . The direct cost of care for psoriasis and psoriatic arthritis in the United States. J Am Acad Dermatol. 2002; 46(6):850-60. DOI: 10.1067/mjd.2002.119669. View

Downes M, Brennan M, Williams H, Dean R . Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016; 6(12):e011458. PMC: 5168618. DOI: 10.1136/bmjopen-2016-011458. View

10.

Khalid J, Globe G, Fox K, Chau D, Maguire A, Chiou C . Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatol. 2013; 13:9. PMC: 3751715. DOI: 10.1186/1471-5945-13-9. View

11.

Stern R, Nijsten T, Feldman S, Margolis D, Rolstad T . Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc. 2004; 9(2):136-9. DOI: 10.1046/j.1087-0024.2003.09102.x. View

12.

Vena G, Altomare G, Ayala F, Berardesca E, Calzavara-Pinton P, Chimenti S . Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database. Eur J Dermatol. 2010; 20(5):593-8. DOI: 10.1684/ejd.2010.1017. View

13.

Griffiths C, Barker J . Pathogenesis and clinical features of psoriasis. Lancet. 2007; 370(9583):263-271. DOI: 10.1016/S0140-6736(07)61128-3. View

14.

Huerta C, Rivero E, Garcia Rodriguez L . Incidence and risk factors for psoriasis in the general population. Arch Dermatol. 2007; 143(12):1559-65. DOI: 10.1001/archderm.143.12.1559. View

15.

Li R, Sun J, Ren L, Wang H, Liu W, Zhang X . Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology (Oxford). 2011; 51(4):721-9. DOI: 10.1093/rheumatology/ker370. View

16.

Bell L, Sedlack R, Beard C, PERRY H, Michet C, Kurland L . Incidence of psoriasis in Rochester, Minn, 1980-1983. Arch Dermatol. 1991; 127(8):1184-7. View

17.

Karimkhani C, Dellavalle R, Coffeng L, Flohr C, Hay R, Langan S . Global Skin Disease Morbidity and Mortality: An Update From the Global Burden of Disease Study 2013. JAMA Dermatol. 2017; 153(5):406-412. PMC: 5817488. DOI: 10.1001/jamadermatol.2016.5538. View

18.

Egeberg A, Skov L, Gislason G, Thyssen J, Mallbris L . Incidence and Prevalence of Psoriasis in Denmark. Acta Derm Venereol. 2017; 97(7):808-812. DOI: 10.2340/00015555-2672. View

19.

Eder L, Widdifield J, Rosen C, Cook R, Lee K, Alhusayen R . Trends in the Prevalence and Incidence of Psoriasis and Psoriatic Arthritis in Ontario, Canada: A Population-Based Study. Arthritis Care Res (Hoboken). 2018; 71(8):1084-1091. DOI: 10.1002/acr.23743. View

20.

Springate D, Parisi R, Kontopantelis E, Reeves D, Griffiths C, Ashcroft D . Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study. Br J Dermatol. 2016; 176(3):650-658. PMC: 5363241. DOI: 10.1111/bjd.15021. View